1. Impact of Adherence to Concomitant Gastroprotective Therapy on Nonsteroidal-Related Gastroduodenal Ulcer Complications 
Jay L. Goldstein, Kimberly B. Howard, Surrey M. Walton, Trent P. Mclaughlin, Denise T. Kruzikas 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 11, Pages 1345.e (November 2006)
DOI: /j.cgh
Copyright © 2006 AGA Institute Terms and Conditions

2. Figure 1
Percent adherence by number of index medication refills. , Adherence 80% or greater; , adherence less than 80%.
Clinical Gastroenterology and Hepatology 2006 4, 1345.e1-1345DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

3. Figure 2
Number of GI events per patient-year by level of adherence in the ns-NSAID cohort.
Clinical Gastroenterology and Hepatology 2006 4, 1345.e1-1345DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

4. Figure 3
Number of GI events per patient-year by level of adherence in the coxib cohort.
Clinical Gastroenterology and Hepatology 2006 4, 1345.e1-1345DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions